H Albert1. 1. Biotec Laboratories Ltd., c/o National Health Laboratory Service, Cape Town, Western Cape, South Africa. alberth@mweb.co.za
Abstract
OBJECTIVE: To compare the cost-effectiveness of three diagnostic algorithms incorporating a new rapid test, FASTPlaqueTB, with the current National TB Control Programme (NTCP) algorithm for diagnosis of pulmonary tuberculosis in new smear-negative suspects in South Africa. DESIGN: A model of the outcome of patients screened using each diagnostic algorithm was established using published costs and performance data for each component of the algorithm. Direct health care provider costs associated with provision of each diagnostic strategy were determined. Overall performance, total cost, speed and accuracy of diagnosis were estimated for screening 1000 new TB suspects using each algorithm. RESULTS: The use of FASTPlaqueTB and culture algorithms enabled 28% more smear-negative TB patients to be diagnosed overall and was cheaper to implement than the NTCP algorithm (18,312-18,581 US dollars compared with 20,079 dollars). Fewer clinic visits were required to establish a diagnosis, reducing clinic workload and patient costs. FASTPlaqueTB enabled rapid and specific diagnosis of at least 50% of smear-negative TB patients within 2 days. CONCLUSIONS: The use of FASTPlaqueTB can assist in improving existing case detection strategies and may be cost-effectively integrated into the current diagnostic infrastructure, offering patients more rapid and reliable diagnosis whilst reducing the overall cost.
OBJECTIVE: To compare the cost-effectiveness of three diagnostic algorithms incorporating a new rapid test, FASTPlaqueTB, with the current National TB Control Programme (NTCP) algorithm for diagnosis of pulmonary tuberculosis in new smear-negative suspects in South Africa. DESIGN: A model of the outcome of patients screened using each diagnostic algorithm was established using published costs and performance data for each component of the algorithm. Direct health care provider costs associated with provision of each diagnostic strategy were determined. Overall performance, total cost, speed and accuracy of diagnosis were estimated for screening 1000 new TB suspects using each algorithm. RESULTS: The use of FASTPlaqueTB and culture algorithms enabled 28% more smear-negative TBpatients to be diagnosed overall and was cheaper to implement than the NTCP algorithm (18,312-18,581 US dollars compared with 20,079 dollars). Fewer clinic visits were required to establish a diagnosis, reducing clinic workload and patient costs. FASTPlaqueTB enabled rapid and specific diagnosis of at least 50% of smear-negative TBpatients within 2 days. CONCLUSIONS: The use of FASTPlaqueTB can assist in improving existing case detection strategies and may be cost-effectively integrated into the current diagnostic infrastructure, offering patients more rapid and reliable diagnosis whilst reducing the overall cost.
Authors: Anuja G Holani; Sindhu M Ganvir; Nishat N Shah; Shriram C Bansode; Ishali Shende; Rashmi Jawade; Shobha C Bijjargi Journal: J Clin Diagn Res Date: 2014-07-20
Authors: Alice Zwerling; Richard G White; Anna Vassall; Ted Cohen; David W Dowdy; Rein M G J Houben Journal: PLoS One Date: 2014-10-23 Impact factor: 3.240
Authors: Adithya Cattamanchi; David W Dowdy; J Lucian Davis; William Worodria; Samuel Yoo; Moses Joloba; John Matovu; Philip C Hopewell; Laurence Huang Journal: BMC Infect Dis Date: 2009-05-06 Impact factor: 3.090
Authors: David W Dowdy; Maria C Lourenço; Solange C Cavalcante; Valeria Saraceni; Bonnie King; Jonathan E Golub; David Bishai; Betina Durovni; Richard E Chaisson; Susan E Dorman Journal: PLoS One Date: 2008-12-29 Impact factor: 3.240